NASDAQ:NTRB Nutriband (NTRB) Stock Price, News & Analysis → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free NTRB Stock Alerts $4.55 -0.30 (-6.19%) (As of 12:55 PM ET) Add Compare Share Share Today's Range$4.54▼$5.0050-Day Range$2.30▼$5.0652-Week Range$1.53▼$6.00Volume18,007 shsAverage Volume36,282 shsMarket Capitalization$49.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Nutriband alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Nutriband Stock (NASDAQ:NTRB)Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Read More NTRB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NTRB Stock News HeadlinesMay 21 at 10:03 AM | finance.yahoo.comJoin Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30May 16, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of DirectorsMay 8, 2024 | theglobeandmail.comNutriband’s (NASDAQ: NTRB) Transdermal Patch with Abuse-Deterrent Tech Funded to Seek FDA ApprovalApril 25, 2024 | finance.yahoo.comIBN Coverage Initiated for Nutriband Inc.April 24, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch Through FDA SubmissionApril 24, 2024 | finance.yahoo.comNutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA SubmissionApril 21, 2024 | uk.investing.comNutriband closes funding for abuse-deterrent fentanyl patchApril 1, 2024 | finance.yahoo.comNutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New BalanceMarch 28, 2024 | marketwatch.comNutriband Shares Rise 30% After Fentanyl Patch Partnership News, Planned FDA SubmissionMarch 27, 2024 | benzinga.comGerald Goodman's Net WorthMarch 27, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA Fentanyl Transdermal PatchMarch 27, 2024 | finance.yahoo.comNutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal PatchJanuary 29, 2024 | finance.yahoo.comNutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1stJanuary 26, 2024 | finanznachrichten.deNutriband Inc.: Nutriband CEO Publishes Letter to ShareholdersJanuary 26, 2024 | finance.yahoo.comNutriband CEO Publishes Letter to ShareholdersJanuary 5, 2024 | finance.yahoo.comNutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl PatchDecember 29, 2023 | morningstar.comNutriband Inc NTRBDecember 18, 2023 | investorplace.comNTRB Stock Earnings: Nutriband Reported Results for Q3 2023November 28, 2023 | finance.yahoo.comNutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and CoolingNovember 28, 2023 | finance.yahoo.comNutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and CoolingOctober 11, 2023 | finance.yahoo.comNutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting FirmSeptember 20, 2023 | finanznachrichten.deFinancialnewsmedia.com: Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the RiseSeptember 20, 2023 | finanznachrichten.deNutriband Inc.: Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent TechnologySeptember 20, 2023 | finance.yahoo.comNutriband Unveils Groundbreaking Innovation in Transdermal MedicationsSeptember 20, 2023 | finance.yahoo.comNutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent TechnologySee More Headlines Receive NTRB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2024Today5/21/2024Next Earnings (Estimated)6/14/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:NTRB CUSIPN/A CIK1676047 Webnutriband.com Phone(407) 377-6695FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,490,000.00 Net Margins-262.94% Pretax Margin-263.07% Return on Equity-73.71% Return on Assets-57.02% Debt Debt-to-Equity Ratio0.01 Current Ratio1.02 Quick Ratio0.85 Sales & Book Value Annual Sales$2.09 million Price / Sales25.46 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book6.64Miscellaneous Outstanding Shares10,970,000Free Float6,236,000Market Cap$53.20 million OptionableNot Optionable Beta0.97 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Serguei Melnik (Age 50)Founder, President, Company Secretary & Executive Chairman of the Board Comp: $200kMr. Gareth Sheridan (Age 34)Founder, CEO & Director Comp: $200kMr. Gerald Goodman (Age 76)CFO & Chief Accounting Officer Comp: $160kDr. Alan Smith Ph.D. (Age 58)COO & President of 4P Therapeutics Comp: $179kMr. Patrick Ryan (Age 38)Chief Technical Officer Dr. Jeffrey Patrick Pharm.D. (Age 54)Chief Scientific Officer Mr. Tyler Overk (Age 40)President of Active Intelligence More ExecutivesKey CompetitorsReWalk RoboticsNASDAQ:LFWDVicarious SurgicalNYSE:RBOTMilestone ScientificNYSE:MLSSLipocineNASDAQ:LPCNEnvoy MedicalNASDAQ:COCHView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 12,862 shares on 5/20/2024Ownership: 0.117%View All Institutional Transactions NTRB Stock Analysis - Frequently Asked Questions How have NTRB shares performed in 2024? Nutriband's stock was trading at $2.32 at the beginning of the year. Since then, NTRB stock has increased by 95.7% and is now trading at $4.54. View the best growth stocks for 2024 here. When is Nutriband's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, June 14th 2024. View our NTRB earnings forecast. How were Nutriband's earnings last quarter? Nutriband Inc. (NASDAQ:NTRB) announced its quarterly earnings results on Tuesday, April, 30th. The company reported ($0.16) earnings per share for the quarter. The business had revenue of $0.53 million for the quarter. Nutriband had a negative trailing twelve-month return on equity of 73.71% and a negative net margin of 262.94%. When did Nutriband's stock split? Nutriband shares split on the morning of Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly issued shares were distributed to shareholders after the closing bell on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split. Who are Nutriband's major shareholders? Nutriband's stock is owned by many different institutional and retail investors. Top institutional shareholders include Virtu Financial LLC (0.12%). How do I buy shares of Nutriband? Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NTRB) was last updated on 5/21/2024 by MarketBeat.com Staff From Our Partners4 Cryptos BETTER than BitcoinTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.